Christine Bruse

No ORCID on file · 14 papers in corpus
rct 2013
·doi:10.1097/01.ogx.0000429298.55211.ad

Dysmenorrhea and infertility are the primary symptoms of endometriosis. Lignocaine (lidocaine, xylocaine) is an anesthetic that stabilizes membranes by blocking the action potential. The drug is used topically to induce local and regional a…

rct 2013
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.12257

OBJECTIVE: Pertubation with lidocaine has been shown to reduce pain (on a VAS-scale) in women with endometriosis. A clinical study was performed to evaluate the effect of lidocaine pertubations on quality of life. DESIGN: Double-blind, ran…

2012
rct 2012
Human Reproduction ·doi:10.1093/humrep/der434

BACKGROUND: Endometriosis is a chronic inflammatory disease of unknown aetiology that can cause severe dysmenorrhea. Lignocaine has anti-inflammatory properties and exerts effects on nerve endings and intra-peritoneal macrophages. The objec…

2012
·doi:10.1016/j.jval.2012.08.1886
lab-animal 2005
Fertility and sterility ·doi:10.1016/j.fertnstert.2004.09.033

OBJECTIVE: To investigate whether separated and cultured endometriotic and endometrial stromal and epithelial cells release urokinase plasminogen activator (uPA), plasminogen activator inhibitor-1 (PAI-1), and soluble plasminogen activator …

2004
·doi:10.1016/j.ics.2004.06.009
other 2004
Molecular human reproduction ·doi:10.1093/molehr/gah033

Endometriotic tissue grows invasively. The plasminogen-activating system is suggested to participate in degradation of extracellular matrix (ECM) and modulation of cell adhesion and migration. We have previously demonstrated elevated levels…

lab-animal 2003
Gynecologic and obstetric investigation ·doi:10.1159/000068950

We have investigated whether there are any differences in the release of urokinase plasminogen activator (uPA) and its inhibitor (PAI-1) from cultured endometrial and endometriotic stromal cells, and whether the release is regulated by epid…

lab-animal 2002
Acta obstetricia et gynecologica Scandinavica ·doi:10.1034/j.1600-0412.2002.810503.x

PROBLEM: To investigate whether endometriotic stromal cells release the urokinase plasminogen activator, soluble urokinase plasminogen activator receptor and plasminogen activator inhibitor-1. If so, to establish if there are any difference…

lab-animal 2002
·doi:10.1080/j.1600-0412.2002.810503.x

ProblemTo investigate whether endometriotic stromal cells release the urokinase plasminogen activator, soluble urokinase plasminogen activator receptor and plasminogen activator inhibitor-1. If so, to establish if there are any differences …

other 2001
Fertility and sterility ·doi:10.1016/s0015-0282(00)01752-0

OBJECTIVE: To compare the levels of IL-1beta, IL-6, and TNFalpha in endometriotic tissue and in endometrium from women with endometriosis and healthy controls. DESIGN: Open. SETTING: Department of Obstetrics and Gynecology at a university…

lab-animal 2000
Gynecologic and obstetric investigation ·doi:10.1159/000010269

The production of IL-1beta, IL-6, IL-8 and TNF-alpha was studied in short-time culture of separated stromal and epithelial cells. The cytokine secretion into culture medium was analyzed using immunoassay to evaluate the cytokine protein lev…

observational 1998
Fertility and sterility ·doi:10.1016/s0015-0282(98)00285-4

OBJECTIVE: To determine whether there is a difference in fibrinolytic compounds in endometriotic tissue, endometrium, peritoneal fluid (PF), and plasma from women with endometriosis and in endometrium and PF from healthy women. DESIGN: Pro…